Announcements

Cannabis legalization in WA state brought a flurry of manufactured products that contain highly concentrated tetrahydrocannabinol (THC), the cannabinoid responsible for cannabis' mind-altering effects. In response, the University of Washington's Addictions, Drug & Alcohol Institute (ADAI) has been contracted by the Washington Health Care Authority (mandated by ESSB 5092) to explore and suggest policy solutions to the public health challenges associated with high-THC products. The ADAI… read more

In conjunction with the Prevention Research Sub-Committee, DBHR’s Prevention Section created three research briefs on emerging substance use and mental health promotion topics. The briefs highlight the benefits and uses of Prevention Science and can be shared with statewide partners. The three briefs, titles, below, are attached.